Matches in Wikidata for { <http://www.wikidata.org/entity/Q80830740> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q80830740 description "article scientifique publié en 2007" @default.
- Q80830740 description "artículu científicu espublizáu n'agostu de 2007" @default.
- Q80830740 description "scientific article published on 01 August 2007" @default.
- Q80830740 description "wetenschappelijk artikel" @default.
- Q80830740 description "наукова стаття, опублікована в серпні 2007" @default.
- Q80830740 name "[Crohn's disease--infliximab, adalimumab and certolizumab-pegol: clinical value of anti-TNF-alpha treatment]" @default.
- Q80830740 name "[Crohn's disease--infliximab, adalimumab and certolizumab-pegol: clinical value of anti-TNF-alpha treatment]" @default.
- Q80830740 type Item @default.
- Q80830740 label "[Crohn's disease--infliximab, adalimumab and certolizumab-pegol: clinical value of anti-TNF-alpha treatment]" @default.
- Q80830740 label "[Crohn's disease--infliximab, adalimumab and certolizumab-pegol: clinical value of anti-TNF-alpha treatment]" @default.
- Q80830740 prefLabel "[Crohn's disease--infliximab, adalimumab and certolizumab-pegol: clinical value of anti-TNF-alpha treatment]" @default.
- Q80830740 prefLabel "[Crohn's disease--infliximab, adalimumab and certolizumab-pegol: clinical value of anti-TNF-alpha treatment]" @default.
- Q80830740 P1104 Q80830740-1EEC2505-AC55-4658-96F4-B0DD882C4CAC @default.
- Q80830740 P1433 Q80830740-7660428E-5BD7-4C85-AF62-84BC177689F1 @default.
- Q80830740 P1476 Q80830740-AB85AD5D-298C-4E2A-A58C-BC459F105271 @default.
- Q80830740 P2093 Q80830740-8F78B454-2C01-4E1D-A525-356D8B64C06A @default.
- Q80830740 P304 Q80830740-017E3A67-2B74-4C17-A4B6-1BF629658A36 @default.
- Q80830740 P31 Q80830740-363B9259-E9EB-4093-AAAB-342E1C61F39F @default.
- Q80830740 P31 Q80830740-40f229fa-38b7-4736-b9f3-d01b02178e63 @default.
- Q80830740 P356 Q80830740-FCA2F7B2-1F93-4AD6-9398-EC4B3A1FEE62 @default.
- Q80830740 P433 Q80830740-3993ABBD-88DD-4314-AA7F-5808A00BAD02 @default.
- Q80830740 P478 Q80830740-24D85221-B200-4755-9D7D-2769A51E9FE4 @default.
- Q80830740 P577 Q80830740-80F4808B-A923-4F99-BC00-70F2E941FFE1 @default.
- Q80830740 P698 Q80830740-DA806F6F-6A62-4FA1-A44D-B7404D9F519A @default.
- Q80830740 P921 Q80830740-2C5666EA-FBB3-4BAE-B9FF-86987DF3AC6A @default.
- Q80830740 P921 Q80830740-834FEF78-8A33-462F-A20B-296B81D039F3 @default.
- Q80830740 P356 S-2007-984966 @default.
- Q80830740 P698 17713889 @default.
- Q80830740 P1104 "+5" @default.
- Q80830740 P1433 Q319640 @default.
- Q80830740 P1476 "[Crohn's disease--infliximab, adalimumab and certolizumab-pegol: clinical value of anti-TNF-alpha treatment]" @default.
- Q80830740 P2093 "S Schreiber" @default.
- Q80830740 P304 "1770-1774" @default.
- Q80830740 P31 Q13442814 @default.
- Q80830740 P31 Q7318358 @default.
- Q80830740 P356 "10.1055/S-2007-984966" @default.
- Q80830740 P433 "34-35" @default.
- Q80830740 P478 "132" @default.
- Q80830740 P577 "2007-08-01T00:00:00Z" @default.
- Q80830740 P698 "17713889" @default.
- Q80830740 P921 Q1472 @default.
- Q80830740 P921 Q348260 @default.